Intercenter differences in bronchopulmonary dysplasia or death among very low birth weight infants

Namasivayam Ambalavanan1, Michele Walsh, Georgiy Bobashev

  • 1Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35249, USA. ambal@uab.edu

Pediatrics
|December 15, 2010
PubMed

Insights

Bronchopulmonary dysplasia or death rates show significant clustering by hospital center. While some infant factors contribute, unmeasured center-specific variables likely explain remaining differences in outcomes for premature infants.

Area of Science:

  • Neonatalogy
  • Perinatal Medicine
  • Clinical Epidemiology

Background:

  • Bronchopulmonary dysplasia (BPD) and death are significant concerns for premature infants.
  • Variability in outcomes across neonatal intensive care units (NICUs) suggests potential differences in care or patient populations.

Purpose of the Study:

  • To quantify the clustering of BPD (36 weeks) or death in neonates with birth weight <1250 g across NIC centers.
  • To identify infant-level and center-specific factors associated with BPD/death.
  • To develop predictive models for BPD/death.

Main Methods:

  • Analysis of data from a cluster-randomized benchmarking trial involving neonates with birth weight <1250 g.
  • Alternating logistic regression and multivariate analysis to assess clustering and identify associated variables.
  • Development of predictive models using center-specific and infant-level data from 2001-2004, projected to 2006.

Main Results:

  • Significant clustering of BPD/death was observed, with pairwise odds ratios of 1.3 (2001-2004) and 1.6 (2006).
  • Center-specific outcomes ranged from 32% to 74%, with relative stability over time.
  • Factors associated with increased risk included lower NICU admission temperature, prophylactic indomethacin, specific day 1 drug therapy, and lack of endotracheal intubation. Clustering persisted after adjusting for these variables.

Conclusions:

  • Moderate clustering of BPD/death rates by NIC center was confirmed.
  • Clinical variables associated with BPD/death were also clustered.
  • Persistent center differences, even after accounting for measured variables, suggest the influence of unmeasured center-specific factors.
Abstract

Related Concept Videos

Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Other Factors Affecting Respiration Centers01:17

Other Factors Affecting Respiration Centers

Breathing is primarily an involuntary activity regulated by the brainstem respiratory centers. However, it can also be consciously controlled, allowing us to hold our breath or take deeper breaths when needed. This voluntary control is facilitated by the cerebral motor cortex, which bypasses the medullary centers to stimulate the respiratory muscles directly.
However, the ability to hold one's breath voluntarily is not limitless. When the CO2 concentration in the blood reaches a critical level,...